108 related articles for article (PubMed ID: 2148926)
1. Elevated levels of soluble CD8 molecule in patients with lymphatic filariasis.
Lal RB; Ramzy RM; Gad AA
Immunol Lett; 1990 Oct; 26(1):85-8. PubMed ID: 2148926
[TBL] [Abstract][Full Text] [Related]
2. Soluble molecules in lymphoproliferative disorders.
Vinante F; Morosato L; De Sabata D; Pizzolo G
Leukemia; 1991; 5 Suppl 1():18-21. PubMed ID: 1653881
[No Abstract] [Full Text] [Related]
3. Shedding of the soluble form of the CD8 complex by CD8+/HLA-DR+ cells in HIV-1-infected patients.
Agostini C; Pizzolo G; Zambello R; Trentin L; Siviero F; Vinante F; Morosato L; Francavilla E; Cadrobbi P; Semenzato G
AIDS; 1991 Jul; 5(7):813-9. PubMed ID: 1832545
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease.
Nishanian P; Hofmann B; Wang Y; Jackson AL; Detels R; Fahey JL
AIDS; 1991 Jul; 5(7):805-12. PubMed ID: 1909873
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD8 levels in the CSF and serum of patients with multiple sclerosis.
Maimone D; Reder AT
Neurology; 1991 Jun; 41(6):851-4. PubMed ID: 1904563
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis.
Yazdanbakhsh M; Sartono E; Kruize YC; Kurniawan A; van der Pouw-Kraan T; van der Meide PH; Selkirk ME; Partono F; Hintzen RQ; van Lier RA
Eur J Immunol; 1993 Dec; 23(12):3312-7. PubMed ID: 7903075
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia.
Ho AD; Grossman M; Trümper L; Pezzutto A; Pralle H; Boedewadt-Radzun S; Papendick U; Göd B; Zwingers T; Hunstein W
Blood; 1990 Mar; 75(5):1119-24. PubMed ID: 2106352
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subpopulations in Bancroftian filariasis: activated (DR+) CD8+ T cells in patients with chronic lymphatic obstruction.
Lal RB; Kumaraswami V; Krishnan N; Nutman TB; Ottesen EA
Clin Exp Immunol; 1989 Jul; 77(1):77-82. PubMed ID: 2527654
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
[TBL] [Abstract][Full Text] [Related]
13. Elevated soluble CD8 in the synovial fluid from patients with rheumatoid arthritis.
Carpenter AB; Eisenbeis CH; Carrabis S; Brown MC; Ip SH
J Clin Lab Anal; 1990; 4(5):337-41. PubMed ID: 2121924
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
[TBL] [Abstract][Full Text] [Related]
15. Increased serum CD8 soluble antigen level is associated with blood lymphocyte abnormalities and other established indicators of a poor prognosis in adult Hodgkin's disease.
Grimfors G; Andersson B; Tullgren O; Giscombe R; Holm G; Johansson B; Björkholm M
Br J Haematol; 1992 Feb; 80(2):166-71. PubMed ID: 1550771
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD8, IL-2 receptor, and tumor necrosis factor-alpha levels in steroid-resistant acute graft-versus-host disease. Relation with subsequent response to anti-IL-2 receptor monoclonal antibody treatment.
Tiberghien P; Racadot E; Lioure B; Delain M; Girard A; Wijdenes J; Plouvier E; Flesch M; Cahn JY; Herve P
Transplantation; 1991 Sep; 52(3):475-80. PubMed ID: 1910217
[TBL] [Abstract][Full Text] [Related]
17. Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell activity.
Weiss C; Wulf G; Ho AD; Hunstein W
Immunol Lett; 1991 Sep; 30(1):113-8. PubMed ID: 1683649
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease.
Griffin DE; McArthur JC; Cornblath DR
J Neuroimmunol; 1990 Jul; 28(2):97-109. PubMed ID: 2113934
[TBL] [Abstract][Full Text] [Related]
20. Fc epsilon receptor II/CD23 positive lymphocytes in atopic dermatitis: II. Infiltration of Fc epsilon R II(+) T cells in the skin lesion.
Sakamoto T; Takigawa M; Tamamori T; Horiguchi D; Yamada M
J Invest Dermatol; 1990 Nov; 95(5):592-6. PubMed ID: 2146324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
